Iovance Biotherapeutics Ownership | Who Owns Iovance Biotherapeutics?
Iovance Biotherapeutics Ownership Summary
Iovance Biotherapeutics is owned by 39.30% institutional investors, 0.36% insiders, and 60.34% retail investors. Mhr fund management is the largest institutional shareholder, holding 8.66% of IOVA shares. State Street® SPDR® S&P® Biotech ETF is the top mutual fund, with 2.94% of its assets in Iovance Biotherapeutics shares.
IOVA Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Iovance Biotherapeutics | 39.30% | 0.36% | 60.34% |
| Sector | Healthcare Stocks | 231.98% | 10.74% | -142.72% |
| Industry | Biotech Stocks | 381.47% | 10.55% | -292.02% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Mhr fund management | 28.97M | 8.66% | $62.86M |
| Blackrock funding, inc. /de | 29.52M | 8.11% | $80.58M |
| Blackrock | 21.23M | 7.97% | $170.23M |
| Vanguard group | 27.21M | 7.47% | $74.28M |
| State street | 20.16M | 5.54% | $55.04B |
| Invenomic capital management lp | 10.54M | 3.15% | $22.88M |
| Long focus capital management | 9.12M | 2.73% | $19.78M |
| Morgan stanley | 9.19M | 2.52% | $25.09M |
| Goldman sachs group | 8.61M | 2.36% | $23.50M |
| Palo alto investors lp | 7.62M | 2.28% | $16.53M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Mhr fund management | 28.97M | 6.16% | $62.86M |
| Palo alto investors lp | 7.62M | 3.06% | $16.53M |
| B group | 1.50M | 2.39% | $3.25M |
| Orion investment | 1.86M | 1.54% | $5.07M |
| Invenomic capital management lp | 10.54M | 1.11% | $22.88M |
| Cm management | 400.00K | 0.92% | $1.09M |
| Parametrica management | 195.88K | 0.82% | $534.75K |
| Long focus capital management | 9.12M | 0.65% | $19.78M |
| Kennondale capital management | 318.19K | 0.53% | $690.47K |
| Mirador capital partners lp | 1.03M | 0.39% | $2.82M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| State street | 20.16M | 0.00% | 6.85M |
| Palo alto investors lp | 7.62M | 3.06% | 4.19M |
| Hrt financial lp | 4.36M | 0.04% | 3.99M |
| Morgan stanley | 9.19M | 0.00% | 3.61M |
| Blackrock funding, inc. /de | 29.52M | 0.00% | 3.56M |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Perceptive advisors | - | - | -12.71M |
| Hood river capital management | - | - | -9.22M |
| Macquarie group | - | - | -4.79M |
| Artisan partners limited partnership | - | - | -4.41M |
| Avoro capital advisors | - | - | -3.50M |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Artal group | 1.01M | 0.21% | 1.01M | $8.11M |
| Susquehanna portfolio strategies | 912.10K | 0.03% | 912.10K | $1.98M |
| Norges bank | 416.24K | 0.00% | 416.24K | $3.08M |
| Cinctive capital management lp | 195.29K | 0.02% | 195.29K | $423.78K |
| Neos investment management | 173.87K | 0.00% | 173.87K | $377.30K |
Sold Out
| Holder | Change |
|---|---|
| Nbc securities | -4.00 |
| Sjs investment consulting | -4.00 |
| Global financial private client | -4.00 |
| Global retirement partners | -5.00 |
| Capital performance advisors llp | -11.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 31, 2025 | 168 | -35.63% | 143,064,086 | -32.81% | 39 | 0.97% | 89 | -29.37% | 43 | -41.89% |
| Sep 30, 2025 | 247 | 0.82% | 212,726,606 | 4.22% | 63 | 1.71% | 118 | -4.07% | 69 | -1.43% |
| Jun 30, 2025 | 250 | -18.03% | 220,042,797 | -8.11% | 65 | 1.20% | 125 | -19.87% | 74 | -16.85% |
| Mar 31, 2025 | 24 | -92.48% | 69,746,593 | -71.12% | 21 | 0.34% | 12 | -92.36% | 4 | -95.40% |
| Dec 31, 2024 | 193 | -35.02% | 100,034,590 | -57.33% | 32 | 0.55% | 92 | -39.07% | 50 | -37.50% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| State Street® SPDR® S&P® Biotech ETF | 12.11M | 2.94% | -65.18K |
| Vanguard Total Stock Mkt Idx Inv | 11.22M | 2.72% | - |
| Vanguard US Total Market Shares ETF | 8.71M | 2.66% | 762.45K |
| iShares Russell 2000 ETF | 7.39M | 1.79% | 4.16M |
| Hood River Small-Cap Growth Instl | 5.10M | 1.53% | - |
| Macquarie Small Cap Core I | 4.08M | 1.22% | 56.67K |
| Invenomic Institutional | 5.01M | 1.22% | 551.34K |
| SPDR® S&P Biotech ETF | 3.56M | 0.98% | 7.96K |
| Vanguard Small Cap Index | 4.05M | 0.98% | -4.99K |
| Vanguard Institutional Extnd Mkt Idx Tr | 3.61M | 0.88% | 15.83K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Jun 05, 2025 | Kirby Daniel Gordon | Chief Commercial Officer | Buy | $55.20K |
| May 23, 2025 | Puri Raj K. | Chief Regulatory Officer | Buy | $9.74K |
| May 14, 2025 | Vogt Frederick G | Interim CEO & General Counsel | Buy | $42.25K |
| Nov 12, 2024 | Maynard Ryan D | - | Sell | $503.00K |
| Feb 20, 2024 | MCPEAK MERRILL A | - | Buy | $2.29M |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2026 Q1 | - | - |
| 2025 Q4 | - | - |
| 2025 Q3 | - | - |
| 2025 Q2 | 3 | - |
| 2025 Q1 | - | - |
IOVA Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools